New review shows why antidepressants often fail in Alzheimer’s and Parkinson’s depression
A recent medical review highlights that standard antidepressants are often ineffective for depression associated with Alzheimer's and Parkinson's diseases. Researchers suggest that future treatments must focus on repairing damaged brain circuits and molecular pathways rather than traditional neurotransmitter modulation.
Why it matters
This research could shift the paradigm for treating neurodegenerative-related mental health issues, potentially improving quality of life for millions of patients.
Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health A-Z Drugs Medical Devices Interviews White Papers More... MediKnowledge eBooks Posters Podcasts Videos Newsletters Health & Personal Care Contact Meet the Team Advertise Search Become a Member Top Health Categories Coronavirus Disease COVID-19 Diet & Nutrition Artificial Intelligence Allergies Alzheimer's & Dementia Arthritis & Rheumatology Breast Cancer Breastfeeding Cold, Flu & Cough Dermatology Diabetes Eating Disorders Eye Health Gastrointestinal Health Heart Disease Lung Cancer Mental Health Parkinson's Disease Pregnancy Sleep Urology View Health A-Z Top Health Categories Coronavirus Disease COVID-19 Eating Disorders Diet & Nutrition Eye Health Artificial Intelligence Gastrointestinal Health Allergies Heart Disease Alzheimer's & Dementia Lung Cancer Arthritis & Rheumatology Mental Health Breast Cancer Parkinson's Disease Breastfeeding Pregnancy Cold, Flu & Cough Sleep Dermatology Urology Diabetes View Health A-Z Medical Home Life Sciences Home About News Life Sciences A-Z White Papers Lab Equipment Interviews Newsletters Webinars More... eBooks Posters Podcasts Videos Contact Meet the Team Advertise Search Become a Member White Papers MediKnowledge eBooks Posters Podcasts Videos Newsletters Health & Personal Care Contact Meet the Team Advertise Search Become a Member Webinars eBooks Posters Podcasts Videos Contact Meet the Team Advertise Search Become a Member New review shows why antidepressants often fail in Alzheimer’s and Parkinson’s depression Download PDF Copy Add News Medical on Google as a preferred source By Hugo Francisco de Souza Reviewed by Susha Cheriyedath, M.Sc. Jul 7 2026 As depression accelerates suffering in Alzheimer's and Parkinson's disease, researchers argue that the next generation of treatments must target the damaged brain circuits and molecular pathways that standard antidepressants often miss.
The report summarizes scientific findings objectively without editorializing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in